Efficacy of On-Demand Therapy Using 20-mg Vonoprazan for Mild Reflux Esophagitis

被引:30
作者
Umezawa, Mariko [1 ]
Kawami, Noriyuki [1 ]
Hoshino, Shintaro [1 ]
Hoshikawa, Yoshimasa [1 ]
Koizumi, Eriko [1 ]
Takenouchi, Nana [1 ]
Hanada, Yuriko [1 ]
Kaise, Mitsuru [1 ]
Iwakiri, Katsuhiko [1 ]
机构
[1] Nippon Med Sch, Grad Sch Med, Dept Gastroenterol, Tokyo, Japan
关键词
Mild reflux esophagitis; Vonoprazan; On-demand therapy; Maintenance therapy; COMPETITIVE ACID BLOCKER; RANDOMIZED CLINICAL-TRIAL; LOS-ANGELES CLASSIFICATION; PROTON PUMP INHIBITORS; EROSIVE ESOPHAGITIS; PERISTALTIC DYSFUNCTION; MAINTENANCE TREATMENT; VS; LANSOPRAZOLE; GASTRIC PH; CROSS-OVER;
D O I
10.1159/000485795
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
\ Background: The study aimed to evaluate the efficacy of on-demand therapy using 20-mg vonoprazan for mild reflux esophagitis (RE). Methods: On-demand therapy by taking one 20-mg tablet of vonoprazan only when reflux symptoms occurred was performed for 24 weeks using 30 patients with mild RE who were receiving maintenance therapy with proton pomp inhibitors (PPIs). The presence or absence of RE, degree of overall satisfaction with the treatment, score of symptoms, and fasting gastrin level before breakfast were examined before and after on-demand therapy. The number of tablets taken during the 24-week period was also noted. Results: One of the 30 patients dropped out of on-demand therapy 1 week after its initiation. Remission was maintained in 25 (86.2%) of the 29 patients (all 10 [100%] Los Angeles classification grade A patients and 15 (78.9%) of the 19 grade B patients). However, 4 grade B patients exhibited grade B relapse. There were no differences in the degree of overall satisfaction, score of symptoms or the gastrin level between PPI and on-demand therapies. The number of vonoprazan tablets taken during the observation period was 33 tablets (median)/24 weeks. Conclusion: On-demand therapy using 20-mg vonoprazan tablets is an effective alternative maintenance therapy for mild RE. (C) 2018 S. Karger AG, Basel
引用
收藏
页码:309 / 315
页数:7
相关论文
共 24 条
  • [1] Randomised clinical trial: vonoprazan, a novel potassium-competitive acid blocker, vs. lansoprazole for the healing of erosive oesophagitis
    Ashida, K.
    Sakurai, Y.
    Hori, T.
    Kudou, K.
    Nishimura, A.
    Hiramatsu, N.
    Umegaki, E.
    Iwakiri, K.
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2016, 43 (02) : 240 - 251
  • [2] Randomised clinical trial: a dose-ranging study of vonoprazan, a novel potassium-competitive acid blocker, vs. lansoprazole for the treatment of erosive oesophagitis
    Ashida, K.
    Sakurai, Y.
    Nishimura, A.
    Kudou, K.
    Hiramatsu, N.
    Umegaki, E.
    Iwakiri, K.
    Chiba, T.
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2015, 42 (06) : 685 - 695
  • [3] Randomized, multicenter study: on-demand versus continuous maintenance treatment with esomeprazole in patients with non-erosive gastroesophageal reflux disease
    Bayerdoerffer, Ekkehard
    Bigard, Marc-Andre
    Weiss, Werner
    Mearin, Fermin
    Rodrigo, Luis
    Dominguez Munoz, Juan Enrique
    Grundling, Hennie
    Persson, Tore
    Svedberg, Lars-Erik
    Keeling, Nanna
    Eklund, Stefan
    [J]. BMC GASTROENTEROLOGY, 2016, 16
  • [4] Time to maximum effect of lansoprazole on gastric pH in normal male volunteers
    Bell, NJV
    Hunt, RH
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 1996, 10 (06) : 897 - 904
  • [5] Intra-gastric pH following single oral administrations of rabeprazole and esomeprazole: double-blind cross-over comparison
    Furuta, Kenji
    Kohata, Yukie
    Fujiwara, Yasuhiro
    Sugimoto, Mitsushige
    Uotani, Takahiro
    Yamade, Mihoko
    Sahara, Shu
    Ichikawa, Hitomi
    Furuta, Takahisa
    Nio, Kenta
    Iwakiri, Ryuichi
    Inamori, Masahiko
    Kawamura, Osamu
    Kusano, Motoyasu
    Kato, Mototsugu
    Kawami, Noriyuki
    Iwakiri, Katsuhiko
    Takeuchi, Toshihisa
    Higuchi, Kazuhide
    Aimi, Masahito
    Naora, Kohji
    Fujimoto, Kazuma
    Arakawa, Tetsuo
    Kinoshita, Yoshikazu
    [J]. JOURNAL OF CLINICAL BIOCHEMISTRY AND NUTRITION, 2014, 55 (03) : 178 - 183
  • [6] GLISE H, 1995, SURG ENDOSC-ULTRAS, V9, P183
  • [7] Efficacy of Vonoprazan for Proton Pump Inhibitor-Resistant Reflux Esophagitis
    Hoshino, Shintaro
    Kawami, Noriyuki
    Takenouchi, Nana
    Umezawa, Mariko
    Hanada, Yuriko
    Hoshikawa, Yoshimasa
    Kawagoe, Tetsuro
    Sano, Hirohito
    Hoshihara, Yoshio
    Nomura, Tsutomu
    Iwakiri, Katsuhiko
    [J]. DIGESTION, 2017, 95 (02) : 156 - 161
  • [8] Esophageal motility in Japanese patients with Barrett's esophagus
    Iwakiri, K
    Sugiura, T
    Hayashi, Y
    Kotoyori, M
    Kawakami, A
    Makino, H
    Nomura, T
    Miyashita, M
    Takubo, K
    Sakamoto, C
    [J]. JOURNAL OF GASTROENTEROLOGY, 2003, 38 (11) : 1036 - 1041
  • [9] Mechanisms underlying excessive esophageal acid exposure in patients with gastroesophageal reflux disease
    Iwakiri, Katsuhiko
    Hoshino, Shintaro
    Kawami, Noriyuki
    [J]. ESOPHAGUS, 2017, 14 (03) : 221 - 228
  • [10] Evidence-based clinical practice guidelines for gastroesophageal reflux disease 2015
    Iwakiri, Katsuhiko
    Kinoshita, Yoshikazu
    Habu, Yasuki
    Oshima, Tadayuki
    Manabe, Noriaki
    Fujiwara, Yasuhiro
    Nagahara, Akihito
    Kawamura, Osamu
    Iwakiri, Ryuichi
    Ozawa, Soji
    Ashida, Kiyoshi
    Ohara, Shuichi
    Kashiwagi, Hideyuki
    Adachi, Kyoichi
    Higuchi, Kazuhide
    Miwa, Hiroto
    Fujimoto, Kazuma
    Kusano, Motoyasu
    Hoshihara, Yoshio
    Kawano, Tatsuyuki
    Haruma, Ken
    Hongo, Michio
    Sugano, Kentaro
    Watanabe, Mamoru
    Shimosegawa, Tooru
    [J]. JOURNAL OF GASTROENTEROLOGY, 2016, 51 (08) : 751 - 767